Diabetes and Barriers to Therapeutic Adherence

Diabetes has long been considered one of the most severe health issues that occur frequently throughout world population. Moreover, the disease triggers numerous other challenges that can be extremely hard to overcome on a daily basis, as the most efficient treatment plans imply constant control over multiple metrics. Emerging evidence suggests that a large percentage of the population does not realize the seriousness of the above-mentioned health issue and tends to name the same excuses for not adhering to all the prescribed measures. Therefore, a dedicate analysis is needed in order to determine the most useful interventions that can be applied broadly and improve lives of millions of patients.

Health care system has proven to be a highly flexible institution, as the seriousness of its duties allows for the rapid development and implementation of multiple strategies seeking to enhance the quality of the treatment process. The data collected and analyzed during the previous parts of the research allow for the development of a sophisticated understanding of treatment refusal. According to Mostafavi et al. (2021), routine daily activities and high stress levels seriously undermine the efficiency of treatment. The phenomenon has been thoroughly analyzed and claimed to be a widespread social issue that is underpinned by a set of common barriers.

Therefore, policymakers working in healthcare should substantially enhance the way communication with clients diagnosed with diabetes is performed. Moreover, according to Rezaei et al. (2019), emphasis on developments and a certain level of pressure on patients is needed. Health officials are to encourage a wide range of initiatives that can be applied on local levels, in every hospital and clinic. Thus, the first intervention implies following basic rational guidelines that prescribe health workers to initiate additional communication with patients that showed vivid lack of interest in adhering to treatment plans.

Given that diabetes is a disease that implies constant control over various health metrics, such attitude cannot be tolerated. Thus, the data provided by nurses should emphasize a patient’s alleged responsibility concerning own health. Siddiqui et al. (2019), claim that a large number of patients cannot afford all the treatment methods prescribed at hospital. Therefore, patients from the high-risk group should be called weekly and advised on the numerous strategies that can make the treatment process as seamless and effortless as possible.

The second intervention is centred around the utilization of modern technologies. All patients diagnosed with diabetes should install Medisafe app, which will allow them to keep track of their progress, which can be essential for extra motivation. The use of the application has proven to be instrumental for overcoming numerous barriers, with financial and social among the most crucial. Thus, information technology specialists developing the application should cooperate with the team of medical professionals in order to provide millions of patients nationwide with a reliable tool that can substantially enhance treatment. Moreover, such type of digitalization should be considered instrumental for decreasing the burden that the current national healthcare system can no longer sustain.

The implications of the above-mentioned interventions for nursing research, education, and practice should not be underestimated, as they provide an entirely new way of cooperation with millions of clients suffering from a serious disease. Thus, nursing research becomes instrumental concerning data collection on patients that reject treatment. The entire education process should incorporate courses on the most efficient communication strategies with a wide range of patients. Practice, meanwhile, will be enhanced substantially by emphasizing the importance of the treatment process that takes place after patients leave hospitals.


Mostafavi, F., Alavijeh, F. Z., Salahshouri, A., & Mahaki, B. (2021). The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study. BioPsychoSocial Medicine, 15(1), 1.

Rezaei, M., Valiee, S., Tahan, M., Ebtekar, F., & Gheshlagh, R. G. (2019). Barriers of medication adherence in patients with type-2 diabetes: A pilot qualitative study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 589-599.

Siddiqui, M. H., Khan, I. A., Moyeen, F., & Chaudhary, K. A. (2019). Identifying barriers to therapeutic adherence in type 2-diabetes: A complex and multidimensional clinical issue. Asploro Journal of Biomedical and Clinical Case Reports, 2019(1), 22.

Cite this paper

Select style


NursingBird. (2023, April 3). Diabetes and Barriers to Therapeutic Adherence. Retrieved from https://nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/


NursingBird. (2023, April 3). Diabetes and Barriers to Therapeutic Adherence. https://nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/

Work Cited

"Diabetes and Barriers to Therapeutic Adherence." NursingBird, 3 Apr. 2023, nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/.


NursingBird. (2023) 'Diabetes and Barriers to Therapeutic Adherence'. 3 April.


NursingBird. 2023. "Diabetes and Barriers to Therapeutic Adherence." April 3, 2023. https://nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/.

1. NursingBird. "Diabetes and Barriers to Therapeutic Adherence." April 3, 2023. https://nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/.


NursingBird. "Diabetes and Barriers to Therapeutic Adherence." April 3, 2023. https://nursingbird.com/diabetes-and-barriers-to-therapeutic-adherence/.